FTXH vs. MHIP

Last updated Jul 15, 2026

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and MHIP (Milliman Healthcare Inflation Plus ETF) are both Health & Biotech Equities funds. FTXH is passively managed, while MHIP is actively managed. A 0.64 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.55%/yr for MHIP.

Performance

FTXH vs. MHIP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Milliman Healthcare Inflation Plus ETF (MHIP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

FTXH

• 1D: -1.37%
• 1M: 4.98%
• 6M: 13.43%
• YTD: 14.98%
• 1Y: 43.98%
• 3Y*: 14.85%
• 5Y*: 9.49%
• 10Y*: —

MHIP

• 1D: -0.52%
• 1M: 1.00%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. MHIP - Yearly Performance Comparison

	2026 (YTD)
FTXH First Trust Nasdaq Pharmaceuticals ETF	9.28%
MHIP Milliman Healthcare Inflation Plus ETF	-0.39%

Correlation

The correlation between FTXH and MHIP is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026	0.64

Return for Risk

FTXH vs. MHIP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH

FTXH Risk / Return Rank: 92
FTXH Sharpe Ratio Rank: 92
FTXH Sortino Ratio Rank: 93
FTXH Omega Ratio Rank: 87
FTXH Calmar Ratio Rank: 95
FTXH Martin Ratio Rank: 92

MHIP

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. MHIP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Milliman Healthcare Inflation Plus ETF (MHIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	FTXH	MHIP	Difference
Sharpe ratio: Return per unit of total volatility	2.51	—	—
Sortino ratio: Return per unit of downside risk	3.72	—	—
Omega ratio: Gain probability vs. loss probability	1.42	—	—
Calmar ratio: Return relative to maximum drawdown	5.92	—	—
Martin ratio: Return relative to average drawdown	17.38	—	—

Drawdowns

FTXH vs. MHIP - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, which is greater than MHIP's maximum drawdown of -3.09%. Use the drawdown chart below to compare losses from any high point for FTXH and MHIP.

Drawdown Indicators

	FTXH	MHIP	Difference
Max Drawdown Largest peak-to-trough decline	-32.11%	-3.09%	-29.02%
Max Drawdown (1Y) Largest decline over 1 year	-7.47%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-19.51%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-19.51%	—	—
Current Drawdown Current decline from peak	-4.40%	-1.99%	-2.41%
Average Drawdown Average peak-to-trough decline	-5.78%	-1.27%	-4.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.55%	—	—

Volatility

Volatility by Period

	FTXH	MHIP	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.70%	—	—
Volatility (6M) Calculated over the trailing 6-month period	12.56%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	17.63%	11.68%	+5.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.51%	11.68%	+4.83%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.44%	11.68%	+6.76%

FTXH vs. MHIP - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than MHIP's 0.55% expense ratio.

Dividends

FTXH vs. MHIP - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.12%, while MHIP has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
FTXH First Trust Nasdaq Pharmaceuticals ETF	1.12%	1.41%	1.66%	1.55%	1.11%	1.03%	0.82%	0.67%	0.91%	2.18%	0.19%
MHIP Milliman Healthcare Inflation Plus ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both FTXH and MHIP in my portfolio?

FTXH and MHIP have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, FTXH or MHIP?

On fees, MHIP is cheaper at 0.55% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, FTXH or MHIP?

MHIP is cheaper with a 0.55% expense ratio, compared with 0.60% for FTXH.

Which ETF pays a higher dividend yield, FTXH or MHIP?

FTXH has the higher dividend yield at 1.12%, compared with 0.00% for MHIP.

What is the main difference between FTXH and MHIP?

They also come from different issuers: First Trust and Milliman. Their fees differ too: 0.60% for FTXH and 0.55% for MHIP.